N 544 150 (Ranitidine 150 mg)

Pill imprint N 544 150 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of gerd; zollinger-ellison syndrome; erosive esophagitis; duodenal ulcer; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ranitidine hydrochloride

Imprint:

N 544 150

Strength:

150 mg

Color:

White

Shape:

Round

Availability:

Rx and/or OTC

Drug Class:

H2 antagonists

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

UDL Laboratories Inc

National Drug Code (NDC):

51079-0879

Inactive Ingredients:

D&C Red No. 30
hydroxypropyl cellulose
hypromellose 2910 (3 mPa.s)
magnesium stearate
microcrystalline cellulose
peppermint
sodium starch glycolate type A potato
titanium dioxide
triethyl citrate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.